Adverse Events Module
For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
Adverse Events Module
Ignite Creation Date:
2025-12-24 @ 5:36 PM
Ignite Modification Date:
2025-12-25 @ 3:07 PM
NCT ID:
NCT00636168
Description:
Adverse Events were collected for the safety population which included all 945 randomized subjects who received at least 1 dose of study therapy (471 in the ipilimumab group and 474 in the placebo group)
Frequency Threshold:
5
Time Frame:
Day 1 up to 70 days after last dose. Up to 10 years.
Study:
NCT00636168
Study Brief:
Efficacy Study of Ipilimumab Versus Placebo to Prevent Recurrence After Complete Resection of High Risk Stage III Melanoma
Serious Events(If Any):
Serious Events
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Lymphadenopathy | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | 22.0 | View |
| Lymphoid tissue hyperplasia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | 22.0 | View |
| Atrial flutter | SYSTEMATIC_ASSESSMENT | Cardiac disorders | 22.0 | View |
| Atrial tachycardia | SYSTEMATIC_ASSESSMENT | Cardiac disorders | 22.0 | View |
| Bifascicular block | SYSTEMATIC_ASSESSMENT | Cardiac disorders | 22.0 | View |
| Cardiac arrest | SYSTEMATIC_ASSESSMENT | Cardiac disorders | 22.0 | View |
| Cardiac failure | SYSTEMATIC_ASSESSMENT | Cardiac disorders | 22.0 | View |
| Cardiopulmonary failure | SYSTEMATIC_ASSESSMENT | Cardiac disorders | 22.0 | View |
| Coronary artery disease | SYSTEMATIC_ASSESSMENT | Cardiac disorders | 22.0 | View |
| Silent myocardial infarction | SYSTEMATIC_ASSESSMENT | Cardiac disorders | 22.0 | View |
| Tachycardia | SYSTEMATIC_ASSESSMENT | Cardiac disorders | 22.0 | View |
| Deafness unilateral | SYSTEMATIC_ASSESSMENT | Ear and labyrinth disorders | 22.0 | View |
| Hypoacusis | SYSTEMATIC_ASSESSMENT | Ear and labyrinth disorders | 22.0 | View |
| Adrenal insufficiency | SYSTEMATIC_ASSESSMENT | Endocrine disorders | 22.0 | View |
| Adrenocorticotropic hormone deficiency | SYSTEMATIC_ASSESSMENT | Endocrine disorders | 22.0 | View |
| Autoimmune thyroiditis | SYSTEMATIC_ASSESSMENT | Endocrine disorders | 22.0 | View |
| Basedow's disease | SYSTEMATIC_ASSESSMENT | Endocrine disorders | 22.0 | View |
| Endocrine disorder | SYSTEMATIC_ASSESSMENT | Endocrine disorders | 22.0 | View |
| Hyperadrenocorticism | SYSTEMATIC_ASSESSMENT | Endocrine disorders | 22.0 | View |
| Hypothyroidism | SYSTEMATIC_ASSESSMENT | Endocrine disorders | 22.0 | View |
| Lymphocytic hypophysitis | SYSTEMATIC_ASSESSMENT | Endocrine disorders | 22.0 | View |
| Thyroiditis | SYSTEMATIC_ASSESSMENT | Endocrine disorders | 22.0 | View |
| Autoimmune uveitis | SYSTEMATIC_ASSESSMENT | Eye disorders | 22.0 | View |
| Episcleritis | SYSTEMATIC_ASSESSMENT | Eye disorders | 22.0 | View |
| Ulcerative keratitis | SYSTEMATIC_ASSESSMENT | Eye disorders | 22.0 | View |
| Uveitis | SYSTEMATIC_ASSESSMENT | Eye disorders | 22.0 | View |
| Abdominal hernia | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 22.0 | View |
| Abdominal pain | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 22.0 | View |
| Abdominal pain lower | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 22.0 | View |
| Anal fissure | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 22.0 | View |
| Autoimmune colitis | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 22.0 | View |
| Colitis | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 22.0 | View |
| Colitis ulcerative | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 22.0 | View |
| Constipation | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 22.0 | View |
| Diarrhoea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 22.0 | View |
| Enteritis | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 22.0 | View |
| Enterocolitis haemorrhagic | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 22.0 | View |
| Gastric haemorrhage | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 22.0 | View |
| Gastritis | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 22.0 | View |
| Gastrointestinal haemorrhage | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 22.0 | View |
| Haemorrhoids | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 22.0 | View |
| Inguinal hernia | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 22.0 | View |
| Intestinal perforation | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 22.0 | View |
| Nausea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 22.0 | View |
| Oesophageal haemorrhage | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 22.0 | View |
| Pancreatitis | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 22.0 | View |
| Pancreatitis acute | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 22.0 | View |
| Rectal haemorrhage | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 22.0 | View |
| Umbilical hernia | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 22.0 | View |
| Vomiting | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 22.0 | View |
| Adverse event | SYSTEMATIC_ASSESSMENT | General disorders | 22.0 | View |
| Fatigue | SYSTEMATIC_ASSESSMENT | General disorders | 22.0 | View |
| Influenza like illness | SYSTEMATIC_ASSESSMENT | General disorders | 22.0 | View |
| Multiple organ dysfunction syndrome | SYSTEMATIC_ASSESSMENT | General disorders | 22.0 | View |
| Pyrexia | SYSTEMATIC_ASSESSMENT | General disorders | 22.0 | View |
| Retention cyst | SYSTEMATIC_ASSESSMENT | General disorders | 22.0 | View |
| Sudden death | SYSTEMATIC_ASSESSMENT | General disorders | 22.0 | View |
| Autoimmune hepatitis | SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | 22.0 | View |
| Cholecystitis | SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | 22.0 | View |
| Hepatitis | SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | 22.0 | View |
| Hepatocellular injury | SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | 22.0 | View |
| Hepatotoxicity | SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | 22.0 | View |
| Hyperbilirubinaemia | SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | 22.0 | View |
| Anaphylactoid reaction | SYSTEMATIC_ASSESSMENT | Immune system disorders | 22.0 | View |
| Autoimmune disorder | SYSTEMATIC_ASSESSMENT | Immune system disorders | 22.0 | View |
| Drug hypersensitivity | SYSTEMATIC_ASSESSMENT | Immune system disorders | 22.0 | View |
| Hypersensitivity | SYSTEMATIC_ASSESSMENT | Immune system disorders | 22.0 | View |
| Bacteraemia | SYSTEMATIC_ASSESSMENT | Infections and infestations | 22.0 | View |
| Bacterial infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | 22.0 | View |
| Beta haemolytic streptococcal infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | 22.0 | View |
| Bronchitis | SYSTEMATIC_ASSESSMENT | Infections and infestations | 22.0 | View |
| Cellulitis | SYSTEMATIC_ASSESSMENT | Infections and infestations | 22.0 | View |
| Cystitis | SYSTEMATIC_ASSESSMENT | Infections and infestations | 22.0 | View |
| Diarrhoea infectious | SYSTEMATIC_ASSESSMENT | Infections and infestations | 22.0 | View |
| Endocarditis | SYSTEMATIC_ASSESSMENT | Infections and infestations | 22.0 | View |
| Erysipelas | SYSTEMATIC_ASSESSMENT | Infections and infestations | 22.0 | View |
| External ear cellulitis | SYSTEMATIC_ASSESSMENT | Infections and infestations | 22.0 | View |
| Gastroenteritis | SYSTEMATIC_ASSESSMENT | Infections and infestations | 22.0 | View |
| Gastroenteritis viral | SYSTEMATIC_ASSESSMENT | Infections and infestations | 22.0 | View |
| Gastrointestinal infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | 22.0 | View |
| Groin infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | 22.0 | View |
| H1N1 influenza | SYSTEMATIC_ASSESSMENT | Infections and infestations | 22.0 | View |
| Localised infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | 22.0 | View |
| Lung infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | 22.0 | View |
| Meningitis | SYSTEMATIC_ASSESSMENT | Infections and infestations | 22.0 | View |
| Meningitis aseptic | SYSTEMATIC_ASSESSMENT | Infections and infestations | 22.0 | View |
| Meningitis bacterial | SYSTEMATIC_ASSESSMENT | Infections and infestations | 22.0 | View |
| Neuroborreliosis | SYSTEMATIC_ASSESSMENT | Infections and infestations | 22.0 | View |
| Osteomyelitis | SYSTEMATIC_ASSESSMENT | Infections and infestations | 22.0 | View |
| Otitis externa | SYSTEMATIC_ASSESSMENT | Infections and infestations | 22.0 | View |
| Perirectal abscess | SYSTEMATIC_ASSESSMENT | Infections and infestations | 22.0 | View |
| Pneumonia | SYSTEMATIC_ASSESSMENT | Infections and infestations | 22.0 | View |
| Post procedural infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | 22.0 | View |
| Sepsis | SYSTEMATIC_ASSESSMENT | Infections and infestations | 22.0 | View |
| Septic embolus | SYSTEMATIC_ASSESSMENT | Infections and infestations | 22.0 | View |
| Skin infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | 22.0 | View |
| Staphylococcal infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | 22.0 | View |
| Wound infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | 22.0 | View |
| Femoral neck fracture | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | 22.0 | View |
| Fracture displacement | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | 22.0 | View |
| Gastrointestinal stoma complication | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | 22.0 | View |
| Incisional hernia | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | 22.0 | View |
| Infusion related reaction | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | 22.0 | View |
| Post procedural complication | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | 22.0 | View |
| Radius fracture | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | 22.0 | View |
| Respiratory tract procedural complication | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | 22.0 | View |
| Seroma | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | 22.0 | View |
| Alanine aminotransferase increased | SYSTEMATIC_ASSESSMENT | Investigations | 22.0 | View |
| Aspartate aminotransferase increased | SYSTEMATIC_ASSESSMENT | Investigations | 22.0 | View |
| Blood corticotrophin decreased | SYSTEMATIC_ASSESSMENT | Investigations | 22.0 | View |
| Blood creatinine increased | SYSTEMATIC_ASSESSMENT | Investigations | 22.0 | View |
| Ejection fraction decreased | SYSTEMATIC_ASSESSMENT | Investigations | 22.0 | View |
| Lymph nodes scan abnormal | SYSTEMATIC_ASSESSMENT | Investigations | 22.0 | View |
| Thyroid function test abnormal | SYSTEMATIC_ASSESSMENT | Investigations | 22.0 | View |
| Transaminases increased | SYSTEMATIC_ASSESSMENT | Investigations | 22.0 | View |
| Weight decreased | SYSTEMATIC_ASSESSMENT | Investigations | 22.0 | View |
| Dehydration | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | 22.0 | View |
| Hypercalcaemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | 22.0 | View |
| Hyperglycaemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | 22.0 | View |
| Hypoglycaemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | 22.0 | View |
| Hypokalaemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | 22.0 | View |
| Hyponatraemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | 22.0 | View |
| Arthralgia | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | 22.0 | View |
| Arthritis | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | 22.0 | View |
| Back pain | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | 22.0 | View |
| Intervertebral disc protrusion | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | 22.0 | View |
| Neck mass | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | 22.0 | View |
| Osteoarthritis | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | 22.0 | View |
| Pain in extremity | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | 22.0 | View |
| Synovial cyst | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | 22.0 | View |
| Adenocarcinoma | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | 22.0 | View |
| Adrenal adenoma | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | 22.0 | View |
| Basal cell carcinoma | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | 22.0 | View |
| Benign lung neoplasm | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | 22.0 | View |
| Central nervous system melanoma | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | 22.0 | View |
| Endobronchial lipoma | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | 22.0 | View |
| Liposarcoma | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | 22.0 | View |
| Malignant melanoma in situ | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | 22.0 | View |
| Malignant neoplasm progression | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | 22.0 | View |
| Malignant pleural effusion | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | 22.0 | View |
| Melanocytic naevus | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | 22.0 | View |
| Melanoma recurrent | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | 22.0 | View |
| Metastases to adrenals | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | 22.0 | View |
| Metastases to bone | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | 22.0 | View |
| Metastases to central nervous system | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | 22.0 | View |
| Metastases to lung | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | 22.0 | View |
| Metastases to lymph nodes | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | 22.0 | View |
| Metastases to skin | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | 22.0 | View |
| Metastasis | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | 22.0 | View |
| Metastatic malignant melanoma | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | 22.0 | View |
| Neoplasm progression | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | 22.0 | View |
| Oncocytoma | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | 22.0 | View |
| Rectal cancer stage 0 | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | 22.0 | View |
| Second primary malignancy | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | 22.0 | View |
| Squamous cell carcinoma | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | 22.0 | View |
| Squamous cell carcinoma of skin | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | 22.0 | View |
| Ataxia | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 22.0 | View |
| Autoimmune neuropathy | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 22.0 | View |
| Axonal neuropathy | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 22.0 | View |
| Carotid artery stenosis | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 22.0 | View |
| Cerebral thrombosis | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 22.0 | View |
| Cranial nerve disorder | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 22.0 | View |
| Guillain-Barre syndrome | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 22.0 | View |
| Haemorrhage intracranial | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 22.0 | View |
| Headache | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 22.0 | View |
| Meningoradiculitis | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 22.0 | View |
| Neuropathy peripheral | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 22.0 | View |
| Peripheral motor neuropathy | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 22.0 | View |
| Peripheral sensory neuropathy | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 22.0 | View |
| Polyneuropathy | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 22.0 | View |
| Presyncope | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 22.0 | View |
| Seizure | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 22.0 | View |
| Spinal cord compression | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 22.0 | View |
| Syncope | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 22.0 | View |
| Trigeminal nerve disorder | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 22.0 | View |
| Confusional state | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | 22.0 | View |
| Depression | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | 22.0 | View |
| Mental status changes | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | 22.0 | View |
| Substance-induced psychotic disorder | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | 22.0 | View |
| Cystitis haemorrhagic | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | 22.0 | View |
| Hydronephrosis | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | 22.0 | View |
| Renal failure | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | 22.0 | View |
| Urinary tract obstruction | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | 22.0 | View |
| Endometrial hyperplasia | SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | 22.0 | View |
| Ovarian cyst | SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | 22.0 | View |
| Eosinophilic pneumonia | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 22.0 | View |
| Hypoxia | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 22.0 | View |
| Interstitial lung disease | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 22.0 | View |
| Lung infiltration | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 22.0 | View |
| Oropharyngeal pain | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 22.0 | View |
| Pneumonitis | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 22.0 | View |
| Pneumothorax | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 22.0 | View |
| Pulmonary embolism | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 22.0 | View |
| Pulmonary granuloma | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 22.0 | View |
| Pulmonary sarcoidosis | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 22.0 | View |
| Actinic keratosis | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 22.0 | View |
| Angioedema | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 22.0 | View |
| Drug eruption | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 22.0 | View |
| Exfoliative rash | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 22.0 | View |
| Pruritus | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 22.0 | View |
| Rash | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 22.0 | View |
| Rash maculo-papular | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 22.0 | View |
| Skin exfoliation | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 22.0 | View |
| Circulatory collapse | SYSTEMATIC_ASSESSMENT | Vascular disorders | 22.0 | View |
| Haematoma | SYSTEMATIC_ASSESSMENT | Vascular disorders | 22.0 | View |
| Hypotension | SYSTEMATIC_ASSESSMENT | Vascular disorders | 22.0 | View |
| Lymphoedema | SYSTEMATIC_ASSESSMENT | Vascular disorders | 22.0 | View |
| Withdrawal hypertension | SYSTEMATIC_ASSESSMENT | Vascular disorders | 22.0 | View |
| Diverticulum intestinal haemorrhagic | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 22.0 | View |
| Duodenal ulcer | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 22.0 | View |
| Dysphagia | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 22.0 | View |
| Asthenia | SYSTEMATIC_ASSESSMENT | General disorders | 22.0 | View |
| Chest pain | SYSTEMATIC_ASSESSMENT | General disorders | 22.0 | View |
| Disease progression | SYSTEMATIC_ASSESSMENT | General disorders | 22.0 | View |
| Disease recurrence | SYSTEMATIC_ASSESSMENT | General disorders | 22.0 | View |
| Sarcoidosis | SYSTEMATIC_ASSESSMENT | Immune system disorders | 22.0 | View |
| Appendicitis | SYSTEMATIC_ASSESSMENT | Infections and infestations | 22.0 | View |
| Appendicitis perforated | SYSTEMATIC_ASSESSMENT | Infections and infestations | 22.0 | View |
| Herpes ophthalmic | SYSTEMATIC_ASSESSMENT | Infections and infestations | 22.0 | View |
| Herpes zoster | SYSTEMATIC_ASSESSMENT | Infections and infestations | 22.0 | View |
| Infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | 22.0 | View |
| Laryngitis | SYSTEMATIC_ASSESSMENT | Infections and infestations | 22.0 | View |
| Tooth infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | 22.0 | View |
| Urinary tract infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | 22.0 | View |
| Viral infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | 22.0 | View |
| Gamma-glutamyltransferase increased | SYSTEMATIC_ASSESSMENT | Investigations | 22.0 | View |
| Influenza A virus test positive | SYSTEMATIC_ASSESSMENT | Investigations | 22.0 | View |
| Lipase increased | SYSTEMATIC_ASSESSMENT | Investigations | 22.0 | View |
| Liver function test increased | SYSTEMATIC_ASSESSMENT | Investigations | 22.0 | View |
| Malignant melanoma | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | 22.0 | View |
| Papillary cystadenoma lymphomatosum | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | 22.0 | View |
| Parathyroid tumour benign | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | 22.0 | View |
| Prostate cancer | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | 22.0 | View |
| Acute coronary syndrome | SYSTEMATIC_ASSESSMENT | Cardiac disorders | 22.0 | View |
| Atrial fibrillation | SYSTEMATIC_ASSESSMENT | Cardiac disorders | 22.0 | View |
| Hyperthyroidism | SYSTEMATIC_ASSESSMENT | Endocrine disorders | 22.0 | View |
| Hypophysitis | SYSTEMATIC_ASSESSMENT | Endocrine disorders | 22.0 | View |
| Hypopituitarism | SYSTEMATIC_ASSESSMENT | Endocrine disorders | 22.0 | View |
| Thrombocytopenia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | 22.0 | View |
Other Events(If Any):
Other Events
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Hypophysitis | SYSTEMATIC_ASSESSMENT | Endocrine disorders | 22.0 | View |
| Hypothyroidism | SYSTEMATIC_ASSESSMENT | Endocrine disorders | 22.0 | View |
| Abdominal pain | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 22.0 | View |
| Colitis | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 22.0 | View |
| Constipation | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 22.0 | View |
| Diarrhoea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 22.0 | View |
| Nausea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 22.0 | View |
| Vomiting | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 22.0 | View |
| Asthenia | SYSTEMATIC_ASSESSMENT | General disorders | 22.0 | View |
| Fatigue | SYSTEMATIC_ASSESSMENT | General disorders | 22.0 | View |
| Influenza like illness | SYSTEMATIC_ASSESSMENT | General disorders | 22.0 | View |
| Oedema peripheral | SYSTEMATIC_ASSESSMENT | General disorders | 22.0 | View |
| Pyrexia | SYSTEMATIC_ASSESSMENT | General disorders | 22.0 | View |
| Nasopharyngitis | SYSTEMATIC_ASSESSMENT | Infections and infestations | 22.0 | View |
| Alanine aminotransferase increased | SYSTEMATIC_ASSESSMENT | Investigations | 22.0 | View |
| Aspartate aminotransferase increased | SYSTEMATIC_ASSESSMENT | Investigations | 22.0 | View |
| Blood lactate dehydrogenase increased | SYSTEMATIC_ASSESSMENT | Investigations | 22.0 | View |
| Blood testosterone decreased | SYSTEMATIC_ASSESSMENT | Investigations | 22.0 | View |
| Lipase increased | SYSTEMATIC_ASSESSMENT | Investigations | 22.0 | View |
| Weight decreased | SYSTEMATIC_ASSESSMENT | Investigations | 22.0 | View |
| Weight increased | SYSTEMATIC_ASSESSMENT | Investigations | 22.0 | View |
| Decreased appetite | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | 22.0 | View |
| Arthralgia | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | 22.0 | View |
| Back pain | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | 22.0 | View |
| Musculoskeletal pain | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | 22.0 | View |
| Myalgia | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | 22.0 | View |
| Pain in extremity | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | 22.0 | View |
| Dizziness | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 22.0 | View |
| Headache | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 22.0 | View |
| Anxiety | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | 22.0 | View |
| Insomnia | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | 22.0 | View |
| Cough | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 22.0 | View |
| Dyspnoea | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 22.0 | View |
| Dermatitis acneiform | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 22.0 | View |
| Pruritus | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 22.0 | View |
| Rash | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 22.0 | View |